Browse By Cancer Type Result Page of OvirusTdb

The total number of records retrieved from this search are 100. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_133Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterYesNoNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻⁶ MOI1% cancer cell deathNoNoNA No responseNANANANA26524593
OV_134Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with tubacin - 1 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻⁶ MOI1% cancer cell deathNoNoNA No responseNANANANA26524593
OV_135Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with tubacin - 2 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻⁶ MOI25% cancer cell deathNoNoNA No responseNANANANA26524593
OV_136Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with tubacin - 5 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻⁶ MOI16% cancer cell deathNoNoNA No responseNANANANA26524593
OV_137Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterYesNoNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻⁵ MOI1% cancer cell deathNoNoNA No responseNANANANA26524593
OV_138Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with tubacin - 1 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻⁵ MOI5% cancer cell deathNoNoNA No responseNANANANA26524593
OV_139Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with tubacin - 2 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻⁵ MOI20% cancer cell deathNoNoNA No responseNANANANA26524593
OV_140Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with tubacin - 5 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻⁵ MOI32% cancer cell deathNoNoNA No responseNANANANA26524593
OV_141Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterYesNoNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻⁴ MOI3% cancer cell deathNoNoNA No responseNANANANA26524593
OV_142Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with tubacin - 1 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻⁴ MOI10% cancer cell deathNoNoNA No responseNANANANA26524593
OV_143Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with tubacin - 2 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻⁴ MOI30% cancer cell deathNoNoNA No responseNANANANA26524593
OV_144Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with tubacin - 5 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻⁴ MOI32% cancer cell deathNoNoNA No responseNANANANA26524593
OV_145Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterYesNoNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻³ MOI15% cancer cell deathNoNoNA No responseNANANANA26524593
OV_146Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with tubacin - 1 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻³ MOI10% cancer cell deathNoNoNA No responseNANANANA26524593
OV_147Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with tubacin - 2 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻³ MOI33% cancer cell deathNoNoNA No responseNANANANA26524593
OV_148Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with tubacin - 5 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻³ MOI51% cancer cell deathNoNoNA No responseNANANANA26524593
OV_149Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterYesNoNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻² MOI20% cancer cell deathNoNoNA No responseNANANANA26524593
OV_150Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with tubacin - 1 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻² MOI26% cancer cell deathNoNoNA No responseNANANANA26524593
OV_151Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with tubacin - 2 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻² MOI49% cancer cell deathNoNoNA No responseNANANANA26524593
OV_152Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with tubacin - 5 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻² MOI98% cancer cell deathNoNoNA No responseNANANANA26524593
OV_153Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterYesNoNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻¹ MOI25% cancer cell deathNoNoNA No responseNANANANA26524593
OV_154Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with tubacin - 1 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻¹ MOI40% cancer cell deathNoNoNA No responseNANANANA26524593
OV_155Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with tubacin - 2 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻¹ MOI54% cancer cell deathNoNoNA No responseNANANANA26524593
OV_156Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with tubacin - 5 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻¹ MOI58% cancer cell deathNoNoNA No responseNANANANA26524593
OV_157Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterYesNoNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay1 MOI28% cancer cell deathNoNoNA No responseNANANANA26524593
OV_158Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with tubacin - 1 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay1 MOI45% cancer cell deathNoNoNA No responseNANANANA26524593
OV_159Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with tubacin - 2 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay1 MOI50% cancer cell deathNoNoNA No responseNANANANA26524593
OV_160Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with tubacin - 5 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay1 MOI58% cancer cell deathNoNoNA No responseNANANANA26524593
OV_161Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterYesNoNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3 MOI30% cancer cell deathNoNoNA No responseNANANANA26524593
OV_162Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with tubacin - 1 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3 MOI40% cancer cell deathNoNoNA No responseNANANANA26524593
OV_163Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with tubacin - 2 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3 MOI50% cancer cell deathNoNoNA No responseNANANANA26524593
OV_164Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with tubacin - 5 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3 MOI70% cancer cell deathNoNoNA No responseNANANANA26524593
OV_165Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterYesNoNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻⁷ MOI5% cancer cell deathNoNoNA No responseNANANANA26524593
OV_166Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with CI994 - 1 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻⁷ MOI10% cancer cell deathNoNoNA No responseNANANANA26524593
OV_167Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with CI994 - 3 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻⁷ MOI10% cancer cell deathNoNoNA No responseNANANANA26524593
OV_168Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterYesNoNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻⁶ MOI9% cancer cell deathNoNoNA No responseNANANANA26524593
OV_169Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with CI994 - 1 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻⁶ MOI6% cancer cell deathNoNoNA No responseNANANANA26524593
OV_170Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with CI994 - 3 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻⁶ MOI3% cancer cell deathNoNoNA No responseNANANANA26524593
OV_171Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterYesNoNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻⁵ MOI15% cancer cell deathNoNoNA No responseNANANANA26524593
OV_172Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with CI994 - 1 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻⁵ MOI10% cancer cell deathNoNoNA No responseNANANANA26524593
OV_173Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with CI994 - 3 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻⁵ MOI5% cancer cell deathNoNoNA No responseNANANANA26524593
OV_174Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterYesNoNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻⁴ MOI40% cancer cell deathNoNoNA No responseNANANANA26524593
OV_175Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with CI994 - 1 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻⁴ MOI44% cancer cell deathNoNoNA No responseNANANANA26524593
OV_176Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with CI994 - 3 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻⁴ MOI43% cancer cell deathNoNoNA No responseNANANANA26524593
OV_177Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterYesNoNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻³ MOI49% cancer cell deathNoNoNA No responseNANANANA26524593
OV_178Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with CI994 - 1 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻³ MOI46% cancer cell deathNoNoNA No responseNANANANA26524593
OV_179Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with CI994 - 3 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻³ MOI42% cancer cell deathNoNoNA No responseNANANANA26524593
OV_180Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterYesNoNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻² MOI51% cancer cell deathNoNoNA No responseNANANANA26524593
OV_181Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with CI994 - 1 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻² MOI52% cancer cell deathNoNoNA No responseNANANANA26524593
OV_182Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with CI994 - 3 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻² MOI52% cancer cell deathNoNoNA No responseNANANANA26524593
OV_183Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterYesNoNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻¹ MOI51% cancer cell deathNoNoNA No responseNANANANA26524593
OV_184Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with CI994 - 1 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻¹ MOI52% cancer cell deathNoNoNA No responseNANANANA26524593
OV_185Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with CI994 - 3 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻¹ MOI52% cancer cell deathNoNoNA No responseNANANANA26524593
OV_186Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterYesNoNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay1 MOI51% cancer cell deathNoNoNA No responseNANANANA26524593
OV_187Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with CI994 - 1 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay1 MOI52% cancer cell deathNoNoNA No responseNANANANA26524593
OV_188Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with CI994 - 3 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay1 MOI52% cancer cell deathNoNoNA No responseNANANANA26524593
OV_189Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterYesNoNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3 MOI54% cancer cell deathNoNoNA No responseNANANANA26524593
OV_190Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with CI994 - 1 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3 MOI52% cancer cell deathNoNoNA No responseNANANANA26524593
OV_191Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with CI994 - 3 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3 MOI60% cancer cell deathNoNoNA No responseNANANANA26524593
OV_886Herpes simplex virusMutantDNAHerpesviridaeDeletion mutant for Gamma 34.5YesNoNoATCCGlioblastoma cell lineU-87 MG3.0E+4 cells per wellNATrypan blue staining and hematocytometer0.1 pfu/ml85% cncer cell killing after 24 hoursNoNoNA No responseNANANANA12788648
OV_889Herpes simplex virusMutantDNAHerpesviridaeDeletion mutant for Gamma 34.5YesNoNoATCCGlioblastoma cell lineU-87 MG3.0E+4 cells per wellNATrypan blue staining and hematocytometer0.1 pfu/ml90% cncer cell killing after 48 hoursNoNoNA No responseNANANANA12788648
OV_892Herpes simplex virusMutantDNAHerpesviridaeDeletion mutant for Gamma 34.5YesNoNoATCCGlioblastoma cell lineU-87 MG3.0E+4 cells per wellNATrypan blue staining and hematocytometer0.01 pfu/ml75% cncer cell killing after 24 hoursNoNoNA No responseNANANANA12788648
OV_895Herpes simplex virusMutantDNAHerpesviridaeDeletion mutant for Gamma 34.5YesNoNoATCCGlioblastoma cell lineU-87 MG3.0E+4 cells per wellNATrypan blue staining and hematocytometer0.01 pfu/ml80% cncer cell killing after 48 hoursNoNoNA No responseNANANANA12788648
OV_1170AdenovirusICOVIR-5DNAAdenoviridaeNoneNoICOVIR-5 in combination with RAD001 drug (0.001 micromolar)NoATCCHuman glioblastoma cell lineU-87 MG5.0E+3 cells per wellNAMTT assay0.1 MOI85% cell survivalNoNoNA No responseNANANANA17557108
OV_1171AdenovirusICOVIR-5DNAAdenoviridaeNoneNoICOVIR-5 in combination with RAD001 drug (0.01 micromolar)NoATCCHuman glioblastoma cell lineU-87 MG5.0E+3 cells per wellNAMTT assay0.1 MOI75% cell survivalNoNoNA No responseNANANANA17557108
OV_1172AdenovirusICOVIR-5DNAAdenoviridaeNoneNoICOVIR-5 in combination with RAD001 drug (0.1 micromolar)NoATCCHuman glioblastoma cell lineU-87 MG5.0E+3 cells per wellNAMTT assay0.1 MOI65% cell survivalNoNoNA No responseNANANANA17557108
OV_1173AdenovirusICOVIR-5DNAAdenoviridaeNoneNoICOVIR-5 in combination with RAD001 drug (10 micromolar)NoATCCHuman glioblastoma cell lineU-87 MG5.0E+3 cells per wellNAMTT assay0.1 MOI40% cell survivalNoNoNA No responseNANANANA17557108
OV_1174AdenovirusICOVIR-5DNAAdenoviridaeNoneNoICOVIR-5 in combination with RAD001 drug (100 micromolar)NoATCCHuman glioblastoma cell lineU-87 MG5.0E+3 cells per wellNAMTT assay0.1 MOI100% cell deathNoNoNA No responseNANANANA17557108
OV_1175AdenovirusICOVIR-5DNAAdenoviridaeNoneNoICOVIR-5 in combination with RAD001 drug (1000 micromolar)NoATCCHuman glioblastoma cell lineU-87 MG5.0E+3 cells per wellNAMTT assay0.1 MOI100% cell deathNoNoNA No responseNANANANA17557108
OV_1176AdenovirusICOVIR-5DNAAdenoviridaeNoneNoICOVIR-5 in combination with RAD001 drug (0.001 micromolar)NoATCCHuman glioblastoma cell lineU-87 MG5.0E+3 cells per wellNAMTT assay1 MOI65% cell survivalNoNoNA No responseNANANANA17557108
OV_1177AdenovirusICOVIR-5DNAAdenoviridaeNoneNoICOVIR-5 in combination with RAD001 drug (0.01 micromolar)NoATCCHuman glioblastoma cell lineU-87 MG5.0E+3 cells per wellNAMTT assay1 MOI55% cell survivalNoNoNA No responseNANANANA17557108
OV_1178AdenovirusICOVIR-5DNAAdenoviridaeNoneNoICOVIR-5 in combination with RAD001 drug (0.1 micromolar)NoATCCHuman glioblastoma cell lineU-87 MG5.0E+3 cells per wellNAMTT assay1 MOI30% cell survivalNoNoNA No responseNANANANA17557108
OV_1179AdenovirusICOVIR-5DNAAdenoviridaeNoneNoICOVIR-5 in combination with RAD001 drug (10 micromolar)NoATCCHuman glioblastoma cell lineU-87 MG5.0E+3 cells per wellNAMTT assay1 MOI10% cell survivalNoNoNA No responseNANANANA17557108
OV_1180AdenovirusICOVIR-5DNAAdenoviridaeNoneNoICOVIR-5 in combination with RAD001 drug (100 micromolar)NoATCCHuman glioblastoma cell lineU-87 MG5.0E+3 cells per wellNAMTT assay1 MOI100% cell deathNoNoNA No responseNANANANA17557108
OV_1181AdenovirusICOVIR-5DNAAdenoviridaeNoneNoICOVIR-5 in combination with RAD001 drug (1000 micromolar)NoATCCHuman glioblastoma cell lineU-87 MG5.0E+3 cells per wellNAMTT assay1 MOI100% cell deathNoNoNA No responseNANANANA17557108
OV_1182AdenovirusICOVIR-5DNAAdenoviridaeNoneNoICOVIR-5 in combination with Temozolomide drug (0.01 micromolar)NoATCCHuman glioblastoma cell lineU-87 MG5.0E+3 cells per wellNAMTT assay0.1 MOI90% cell survivalNoNoNA No responseNANANANA17557108
OV_1183AdenovirusICOVIR-5DNAAdenoviridaeNoneNoICOVIR-5 in combination with Temozolomide drug (0.1 micromolar)NoATCCHuman glioblastoma cell lineU-87 MG5.0E+3 cells per wellNAMTT assay0.1 MOI60% cell survivalNoNoNA No responseNANANANA17557108
OV_1184AdenovirusICOVIR-5DNAAdenoviridaeNoneNoICOVIR-5 in combination with Temozolomide drug (10 micromolar)NoATCCHuman glioblastoma cell lineU-87 MG5.0E+3 cells per wellNAMTT assay0.1 MOI30% cell survivalNoNoNA No responseNANANANA17557108
OV_1185AdenovirusICOVIR-5DNAAdenoviridaeNoneNoICOVIR-5 in combination with Temozolomide drug (1000 micromolar)NoATCCHuman glioblastoma cell lineU-87 MG5.0E+3 cells per wellNAMTT assay0.1 MOI100% cell deathNoNoNA No responseNANANANA17557108
OV_1186AdenovirusICOVIR-5DNAAdenoviridaeNoneNoICOVIR-5 in combination with Temozolomide drug (0.01 micromolar)NoATCCHuman glioblastoma cell lineU-87 MG5.0E+3 cells per wellNAMTT assay1 MOI70% cell survivalNoNoNA No responseNANANANA17557108
OV_1187AdenovirusICOVIR-5DNAAdenoviridaeNoneNoICOVIR-5 in combination with Temozolomide drug (0.1 micromolar)NoATCCHuman glioblastoma cell lineU-87 MG5.0E+3 cells per wellNAMTT assay1 MOI30% cell survivalNoNoNA No responseNANANANA17557108
OV_1188AdenovirusICOVIR-5DNAAdenoviridaeNoneNoICOVIR-5 in combination with Temozolomide drug (10 micromolar)NoATCCHuman glioblastoma cell lineU-87 MG5.0E+3 cells per wellNAMTT assay1 MOI20% cell survivalNoNoNA No responseNANANANA17557108
OV_1189AdenovirusICOVIR-5DNAAdenoviridaeNoneNoICOVIR-5 in combination with Temozolomide drug (1000 micromolar)NoATCCHuman glioblastoma cell lineU-87 MG5.0E+3 cells per wellNAMTT assay1 MOI100% cell deathNoNoNA No responseNANANANA17557108
OV_1190AdenovirusICOVIR-5DNAAdenoviridaeNoneNoICOVIR-5 in combination with RAD001 drug (5mg/kg for 5 days)NoATCCHuman glioblastoma cell lineU-87 MGNANANANANAAthymic nude mice xenograft for U87MG cells1.0E+7 pfu NA Complete reduction of tumor after 90 days in 20-40% of animalsNANANANA17557108
OV_1191AdenovirusICOVIR-5DNAAdenoviridaeNoneNoICOVIR-5 in combination with Temozolomide drug (7.5mg/kg for 5 days)NoATCCHuman glioblastoma cell lineU-87 MGNANANANANAAthymic nude mice xenograft for U87MG cells1.0E+7 pfu NA Complete reduction of tumor after 90 days in 20-40% of animalsNANANANA17557108
OV_1649Herpes simplex virusHSV-1DNAHerpesviridaeNoneYesNoVirus expressing vstat120 geneATCCHuman glioma cell lineLN22NANACrystal violet staining0.05 MOI90% cell survival after 3 daysNoNoNA No responseNANANANA19844198
OV_1650Herpes simplex virusHSV-1DNAHerpesviridaeNoneYesNoVirus expressing vstat120 geneATCCHuman glioma cell lineLN22NANACrystal violet staining0.1 MOI90% cell survival after 3 daysNoNoNA No responseNANANANA19844198
OV_1651Herpes simplex virusHSV-1DNAHerpesviridaeNoneYesNoVirus expressing vstat120 geneATCCHuman glioma cell lineLN22NANACrystal violet staining0.5 MOI30% cell survival after 3 daysNoNoNA No responseNANANANA19844198
OV_1652Herpes simplex virusHSV-1DNAHerpesviridaeNoneYesNoVirus expressing vstat120 geneATCCHuman glioma cell lineLN22NANACrystal violet staining1 MOI20% cell survival after 3 daysNoNoNA No responseNANANANA19844198
OV_1653Herpes simplex virusHSV-1DNAHerpesviridaeNoneYesNoVirus expressing vstat120 geneATCCHuman glioma cell lineU87deltaEGFRNANACrystal violet staining0.05 MOI70% cell survival after 3 daysNoNoNA No responseNANANANA19844198
OV_1654Herpes simplex virusHSV-1DNAHerpesviridaeNoneYesNoVirus expressing vstat120 geneATCCHuman glioma cell lineU87deltaEGFRNANACrystal violet staining0.1 MOI60% cell survival after 3 daysNoNoNA No responseNANANANA19844198
OV_1655Herpes simplex virusHSV-1DNAHerpesviridaeNoneYesNoVirus expressing vstat120 geneATCCHuman glioma cell lineU87deltaEGFRNANACrystal violet staining0.5 MOI10% cell survival after 3 daysNoNoNA No responseNANANANA19844198
OV_1656Herpes simplex virusHSV-1DNAHerpesviridaeNoneYesNoVirus expressing vstat120 geneATCCHuman glioma cell lineU87deltaEGFRNANACrystal violet staining1 MOI100% cell death after 3 daysNoNoNA No responseNANANANA19844198
OV_1657Herpes simplex virusHSV-1DNAHerpesviridaeNoneYesNoVirus expressing vstat120 geneATCCHuman glioma cell lineGlideltaEGFR-H2B-RFPNANACrystal violet staining0.05 MOI70% cell survival after day 3NoNoNA No responseNANANANA19844198
OV_1658Herpes simplex virusHSV-1DNAHerpesviridaeNoneYesNoVirus expressing vstat120 geneATCCHuman glioma cell lineGlideltaEGFR-H2B-RFPNANACrystal violet staining0.1 MOI40% cell survival after day 3NoNoNA No responseNANANANA19844198
OV_1659Herpes simplex virusHSV-1DNAHerpesviridaeNoneYesNoVirus expressing vstat120 geneATCCHuman glioma cell lineGlideltaEGFR-H2B-RFPNANACrystal violet staining0.5 MOI100% cell death after 3 daysNoNoNA No responseNANANANA19844198
OV_1660Herpes simplex virusHSV-1DNAHerpesviridaeNoneYesNoVirus expressing vstat120 geneATCCHuman glioma cell lineGlideltaEGFR-H2B-RFPNANACrystal violet staining1 MOI100% cell death after 3 daysNoNoNA No responseNANANANA19844198
OV_1661Herpes simplex virusHSV-1DNAHerpesviridaeNoneYesNoVirus expressing vstat120 geneATCCHuman glioma cell lineU343NANACrystal violet staining0.05 MOI100% cell survival after day 3NoNoNA No responseNANANANA19844198
OV_1662Herpes simplex virusHSV-1DNAHerpesviridaeNoneYesNoVirus expressing vstat120 geneATCCHuman glioma cell lineU343NANACrystal violet staining0.1 MOI90% cell survival after 3 daysNoNoNA No responseNANANANA19844198
OV_1663Herpes simplex virusHSV-1DNAHerpesviridaeNoneYesNoVirus expressing vstat120 geneATCCHuman glioma cell lineU343NANACrystal violet staining0.5 MOI40% cell survival after day 3NoNoNA No responseNANANANA19844198